METAMORPHIX INC has a total of 41 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are BABRAHAM INST, ELEANOR ROOSEVELT INST and S I S S A SCUOLA INTERNAZ SUPE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Canada | 5 | |
#5 | Brazil | 3 | |
#6 | Hong Kong | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Argentina | 1 | |
#9 | China | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Measurement | |
#5 | Machines | |
#6 | Environmental technology | |
#7 | Computer technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care | |
#5 | Medical preparations | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes | |
#8 | Unspecified technologies | |
#9 | Climate change adaptation technologies | |
#10 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Liang Li-Fang | 20 |
#2 | Topouzis Stavros | 13 |
#3 | Rosenfeld David | 8 |
#4 | Wright Jill F | 7 |
#5 | Sinha Debasish | 7 |
#6 | Elvin Julia Andrea | 7 |
#7 | Holm Tom | 7 |
#8 | Matzuk Martin Matthew | 7 |
#9 | Ratovitski Tamara | 7 |
#10 | Bates Stephen | 7 |
Publication | Filing date | Title |
---|---|---|
AU2007202541A1 | Growth differentiation factor promoter and uses therefor | |
AU2003200428B2 | Growth differentiation factor-9 regulatory sequences and uses therefor | |
CN1355881A | Suppress the active polypeptide of growth and differentiation factor and express the cell of this polypeptide | |
AU5542799A | Growth differentiation factor promoter and uses therefor | |
EP1098661A2 | Gnrh vaccines for suppressing reproductive behavior in animals | |
EP1075272A1 | Methods for treating diabetes by inhibiting gdf-8 | |
US7227013B1 | Growth differentiation factor-9 regulatory sequences and uses therefor | |
CA2324286A1 | Growth differentiation factor-9 regulatory sequences and uses therefor |